What patients experience with medullary thyroid cancer
Part of Cancer clinical trials.
This study is looking at what people with medullary thyroid cancer go through during treatment. It aims to understand their experiences to help improve care and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of medullary thyroid cancer (a type of thyroid cancer).
- You must be at least 18 years old.
- You must be able to understand and agree to take part in the study (provide consent).
- You must not have serious or unstable medical or mental health conditions that could interfere with the study.
- You must not be currently taking any other experimental (investigational) drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to help guide surgery for medullary thyroid cancer (MTC). The goal is to see if this scan can make surgery more precise.
This study follows people with medullary thyroid cancer to better understand how the disease changes over time, including in advanced stages. You may help improve future treatment planning and care for people with medullary thyroid cancer.
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This study looks at medical records to see if certain medications might be linked to a rare thyroid cancer (medullary thyroid carcinoma). You don't need to do anything new—just your existing health data will be reviewed.
This study looks at thyroid cancer and how standard treatments and other health details relate to outcomes. You might be eligible if you have thyroid cancer and can participate by giving informed consent.
Hear when a new Medullary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.